Polsinelli Podcasts - FDA Denies Amgen Citizen Petition in Biosimilar Dispute
Sandoz Inc. announced on October 2, 2015 that FDA accepted its regulatory application for a proposed biosimilar of Amgen Inc.’s biologic arthritis drug Enbrel for review. The acceptance comes years after Sandoz attempted to...more